Coexpression of CD9 augments the ability of membrane-bound heparin- binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability

Kidney International

Volumn 55, Issue 1, 1999, Pages 71-81

  Takemura, Tsukasa ^b   Hino, Satoshi ^b   Murata, Yuka ^b   Yanagida, Hidehiko ^b   Okada, Mitsuru ^b   Yoshioka, Kazuo ^b   Harris, Raymond C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Cell growth; Extracellular matrix; Growth factor; Heparin binding; NRK 52E cells

Indexed keywords

CD9 ANTIGEN; EPIDERMAL GROWTH FACTOR DERIVATIVE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL INTERACTION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; KIDNEY EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 0006142676     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00259.x     Document Type: Article

References (52)

1. Massague J: Transforming growth factors-α. J Biol Chem 265: 21393-21396, 1990
2. Lupulescu AP: Hormones, vitamins, and growth factors in cancer treatment and prevention: A critical appraisal. Cancer 78:2264-2280, 1996
3. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD: Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262:695-700, 1993
4. Coles HS, Burne JF, Raff MC: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118:777-784, 1993
5. Koseki C, Herzlinger D, Al-Awqati Q: Apoptosis in metanephric development. J Cell Biol 119:1327-1333, 1992
6. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M: A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251:936-939, 1991
7. Higashiyama S, Lau K, Besner GE, Abraham JA, Klagsbrun M: Structure of heparin-binding EGF-like growth factor: Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 267:6205-6212, 1992
8. Ono M, Raab G, Lau K, Abraham JA, Klagsbrun M: Purification and characterization of transmembrane forms of heparin-binding EGF-like growth factor. J Biol Chem 269:31315-31321, 1994
9. Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E, Taniguchi N: Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: Conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell 6:967-980, 1995
10. Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, Mekada E: The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol 128:929-938, 1995
11. Takemura T, Kondo S, Homma T, Sakai M, Harris RC: The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells. J Biol Chem 272:31036-31042, 1997
12. Inui S, Higashiyama S, Hashimoto K, Higashiyama M, Yoshikawa K, Taniguchi N: Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth. J Cell Physiol 171:291-298, 1997
13. Homma T, Sakai M, Cheng HF, Yasuda T, Coffey RJ Jr, Harris RC: Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J Clin Invest 96:1018-1025, 1995
14. Sakai M, Zhang M, Homma T, Garrick B, Abraham JA, McKanna JA, Harris RC: Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury: Isolation and localization of bioactive molecules. J Clin Invest 99:2128-2138, 1997
15. Morgan DM: Tetrazolium (MTT) assay for cellular viability and activity. Methods Mol Biol 79:179-183, 1998
16. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
17. Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K: Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int 48:1886-1892, 1995
18. 2+-dependent endonuclease, caspase-3 and stress activated protein kinases. Exp Cell Res 239:411-422, 1998
19. Creely JJ, Commers PA, Haralson MA: Synthesis of type III collagen by cultured kidney epithelial cells. Connect Tissue Res 18:107-122, 1988
20. Bonventre JV: Mechanisms of ischemic acute renal failure. Kidney Int 41:226-246, 1993
21. Toback FG: Regeneration after acute tubular necrosis. Kidney Int 41:226-246, 1992
22. Nouwen EJ, Verstrepen WA, Buyssens N, Zhu MQ, De Broe ME: Hyperplasia, hypertrophy, and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab Invest 70:479-493, 1994
23. Schumer M, Colombel MC, Sawczuk IS, Gobe G, Connor J, O'Toole KM, Olsson CA, Wise GJ, Buttyan R: Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-838, 1992
24. Racusen LC: Alterations in human proximal tubule cell attachment in response to hypoxia: Role of microfilaments. J Lab Clin Med 123:357-364, 1994
25. Racusen LC: Alterations in tubular epithelial cell adhesion and mechanisms of acute renal failure. Lab Invest 67:158-165, 1992
26. Molitoris BA, Wagner MC: Surface membrane polarity of proximal tubular cells: Alterations as a basis for malfunction. Kidney Int 49:1592-1597, 1996
27. Goligorsky MS, Lieberthal W, Racusen L, Simon EE: Integrin receptors in renal tubular epithelium: New insights into pathophysiology of acute renal failure. (editorial) Am J Physiol 264:F1-F8, 1993
28. Safirstein R, Price PM, Saggi SJ, Harris RC: Changes in gene expression after temporary renal ischemia. Kidney Int 37:1515-1521, 1990
29. Behrens MT, Corbin AL, Hise MK: Epidermal growth factor receptor regulation in the rat kidney: Two models of renal growth. Am J Physiol 257:F1059-F1064, 1989
30. Yoshizumi M, Kourembanas S, Temizer DH, Cambria RP, Quertermous T, Lee ME: Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J Biol Chem 267:9467-9469,1992
31. Barnard JA, Graves-Deal R, Pittelkow MR, Dubois R, Cook P, Ramsey GW, Bishop PR, Damstrup L, Coffey RJ: Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol Chem 269:22817-22822, 1994
32. Higashiyama S, Abraham JA, Klagsbrun M: Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: Dependence on interactions with cell surface heparan sulfate. J Cell Biol 122:933-940, 1993
33. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, Klagsbrun M: Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 90:3889-3893, 1993
34. Naglich JG, Metherall JE, Russell DW, Eidels L: Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor. Cell 69:1051-1061, 1992
35. Iwamoto R, Higashiyama S, Mitamura T, Taniguchi N, Klagsbrun M, Mekada E: Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J 13:2322-2330, 1994
36. Maecker HT, Todd SC, Levy S: The tetraspanin superfamily: Molecular facilitators. FASEB J 11:428-442, 1997
37. Kaprielian Z, Cho KO, Hadjiargyrou M, Patterson PH: CD9, a major platelet cell surface glycoprotein, is a ROCA antigen and is expressed in the nervous system. J Neuroscience 15:562-573, 1995
38. Sincock PM, Mayrhofer G, Ashman LK: Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: Comparison with CD9, CD63, and alpha-5beta1 integrin. J Histochem Cytochem 45:515-525, 1997
39. Davis ID, Lebien TW, Lindman BJ, Platt JL: Biochemical and histochemical characterization of a murine tubular antigen. J Am Soc Nephrol 1:1153-1161, 1991
40. Platt JL, Lebien TW, Michael AF: Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemopoietic differentiation antigens. J Exp Med 157:155-172, 1983
41. Sheikh-Hamad D, Ferraris JD, Dragolovich J, Preuss HG, Burg MB, Garcia-Perez A: CD9 antigen mRNA is induced by hypertonicity in two renal epithelial cell lines. Am J Physiol 270:C253-C258, 1996
42. Whorwood CB, Ricketts ML, Stewart PM: Regulation of sodium-potassium adenosine triphosphate subunit gene expression by corticosteroids and 11 beta-hydroxysteroid dehydrogenase activity. Endocrinology 135:901-910, 1994
43. Stewart PM, Whorwood CB: 11 Beta-hydroxysteroid dehydrogenase activity and corticosteroid hormone action. Steroids 59:90-95, 1994
44. Nakamura K, Iwamoto R, Mekada E: Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J Cell Biol 129:1691-1705, 1995
45. Fukuyama R, Shimizu N: Detection of epidermal growth factor receptors and E-cadherins in the basolateral membrane of A431 cells by laser scanning fluorescence microscopy. Jpn J Cancer Res 82:8-11, 1991
46. Larjava H, Peltonen J, Akiyama SK, Yamada SS, Gralnick HR, Uitto J, Yamada KM: Novel function for beta 1 integrins in keratinocyte cell-cell interactions. J Cell Biol 110:803-815, 1990
47. Simon EE, Liu CH, Das M, Nigam S, Broekelmann TJ, McDonald JA: Characterization of integrins in cultured human renal cortical tubule epithelial cells. Am J Physiol 267:F612-F623, 1994
48. Carter WG, Wayner EA, Bouchard TS, Kaur P: The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol 110:1387-1404, 1990
49. Cajot JF, Sordat I, Silvestre T, Sordat B: Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res 57:2593-2597, 1997
50. Higashiyama M, Doi O, Kodama K, Yokouchi H, Adachi M, Huang CL, Taki T, Kasugai T, Ishiguro S, Nakamori S, Miyake M: Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Int J Cancer 74:205-211, 1997
51. Miyake M, Nakano K, Itoi SI, Koh T, Taki T: Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res 56:1244-1249, 1996
52. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M: Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 177:1231-1237, 1993